Ms Annaruth Kelley Urbonowicz, CPNP | |
1792 Merritt Blvd, Dundalk, MD 21222 | |
(410) 284-1133 | |
(410) 284-3371 |
Full Name | Ms Annaruth Kelley Urbonowicz |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Location | 1792 Merritt Blvd, Dundalk, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770772196 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | R159487 (Maryland) | Secondary |
363L00000X | Nurse Practitioner | R159487 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Annaruth Kelley Urbonowicz, CPNP 1792 Merritt Blvd, Dundalk, MD 21222 Ph: (410) 284-1133 | Ms Annaruth Kelley Urbonowicz, CPNP 1792 Merritt Blvd, Dundalk, MD 21222 Ph: (410) 284-1133 |
News Archive
Zila, leader in the prevention and detection of oral diseases, today introduced an angled exam mirror as part of the ViziLite Plus oral lesion identification and marking system. The autoclavable mirror attaches to the top of the ViziLite Plus lightstick retractor, enhancing dental professionals' ability to see oral lesions during a comprehensive oral cancer screening procedure.
Temporary staff members working in a hospital's fast-paced emergency department are twice as likely as permanent employees to be involved in medication errors that harm patients, new Johns Hopkins research suggests.
Accelera Innovations, Inc. a Chicago-based healthcare software-as-a-service provider (the "Company") today announced it has entered into a Standby Equity Purchase Agreement ("Investment Agreement") with Lambert Private Equity, LLC, (the "Investor").
Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis.
› Verified 7 days ago